CRISPR Therapeutics AG

Report date
12/31/2024
Quarter
2024 Q4
Filed
2/13/2025
Shares
18,097
Value ($000)
712
Weight
0.0%
2019 Q4 - 2024 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).